Inovio Pharmaceuticals Company Profile (NASDAQ:INO)

About Inovio Pharmaceuticals

Inovio Pharmaceuticals logoInovio Pharmaceuticals, Inc. (Inovio) is a bio-pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), influenza, Ebola, Middle East respiratory syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, the Company has a pipeline of pre-clinical and clinical stage products that have generated in vivo (in the body) immune responses.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: INO
  • CUSIP:
Key Metrics:
  • Previous Close: $9.44
  • 50 Day Moving Average: $9.09
  • 200 Day Moving Average: $9.45
  • 52-Week Range: $4.50 - $11.69
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.80
  • P/E Growth: 0.00
  • Market Cap: $709.00M
  • Outstanding Shares: 73,548,000
  • Beta: 2.89
Profitability:
  • Net Margins: -88.19%
  • Return on Equity: -22.29%
  • Return on Assets: -18.21%
Debt:
  • Current Ratio: 4.17%
  • Quick Ratio: 4.17%
Additional Links:
Companies Related to Inovio Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Inovio Pharmaceuticals (NASDAQ:INO) (?)
Ratings Breakdown: 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $18.33 (94.21% upside)

Analysts' Ratings History for Inovio Pharmaceuticals (NASDAQ:INO)
Show:
DateFirmActionRatingPrice TargetDetails
8/29/2016HC WainwrightInitiated CoverageBuy$17.00View Rating Details
8/18/2016Maxim GroupReiterated RatingHoldView Rating Details
8/8/2016Brean CapitalSet Price TargetBuy$18.00View Rating Details
8/8/2016Piper Jaffray Cos.Reiterated RatingOverweight$31.00View Rating Details
7/17/2016Stifel NicolausReiterated RatingBuy$13.00View Rating Details
6/21/2016Rodman & RenshawReiterated RatingBuy$17.00View Rating Details
(Data available from 9/27/2014 forward)

Earnings

Earnings History for Inovio Pharmaceuticals (NASDAQ:INO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/8/2016Q2($0.21)($0.26)$4.95 million$6.20 millionViewN/AView Earnings Details
5/9/2016Q1($0.14)($0.11)$4.75 million$8.10 millionViewN/AView Earnings Details
3/14/2016Q4($0.20)($0.25)$6.96 million$5.94 millionViewListenView Earnings Details
11/9/2015Q3$0.04$0.07$1.84 million$24.18 millionViewN/AView Earnings Details
8/10/2015Q215($0.13)($0.10)$5.52 million$5.30 millionViewListenView Earnings Details
5/11/2015Q1($0.11)($0.18)$7.04 million$5.20 millionViewListenView Earnings Details
3/16/2015Q414($0.10)($0.12)$5.24 million$2.50 millionViewN/AView Earnings Details
11/10/2014Q314($0.14)($0.12)$5.60 million$1.80 millionViewN/AView Earnings Details
8/11/2014Q214($0.19)($0.18)$1.80 million$3.80 millionViewN/AView Earnings Details
5/12/2014Q114($0.04)($0.05)$1.41 million$2.40 millionViewN/AView Earnings Details
3/17/2014Q413($0.03)($0.04)$1.36 million$1.70 millionViewN/AView Earnings Details
11/11/2013Q3($0.02)($0.16)$2.99 million$9.50 millionViewListenView Earnings Details
11/7/2012Q312($0.05)($0.05)$2.07 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Inovio Pharmaceuticals (NASDAQ:INO)
Current Year EPS Consensus Estimate: $-0.92 EPS
Next Year EPS Consensus Estimate: $-1.21 EPS

Dividends

Dividend History for Inovio Pharmaceuticals (NASDAQ:INO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Inovio Pharmaceuticals (NASDAQ:INO)
Insider Ownership Percentage: 9.90%
Institutional Ownership Percentage: 28.58%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/29/2016Niranjan SardesaiCOOSell21,800$9.30$202,740.00View SEC Filing  
6/28/2016Morton CollinsDirectorBuy10,000$9.13$91,300.00View SEC Filing  
5/18/2016Simon X BenitoDirectorSell6,250$10.37$64,812.50View SEC Filing  
4/15/2016Morton CollinsDirectorBuy68,400$9.52$651,168.00View SEC Filing  
9/30/2015Niranjan SardesaiCOOBuy4,000$5.50$22,000.00View SEC Filing  
8/14/2015Simon X BenitoDirectorBuy6,000$7.21$43,260.00View SEC Filing  
4/13/2015Angel CabreraDirectorBuy8,000$9.53$76,240.00View SEC Filing  
10/9/2014Peter KiesCFOBuy3,960$10.10$39,996.00View SEC Filing  
8/21/2014Morton CollinsDirectorBuy8,000$10.01$80,080.00View SEC Filing  
8/20/2014Morton CollinsDirectorBuy40,600$9.74$395,444.00View SEC Filing  
8/12/2014Jong Joseph KimCEOBuy250,000$9.06$2,265,000.00View SEC Filing  
8/12/2014Niranjan SardesaiCOOBuy2,550$8.70$22,185.00View SEC Filing  
4/15/2014Jong Joseph KimCEOBuy25,000$2.25$56,250.00View SEC Filing  
11/13/2013Morton CollinsDirectorBuy254,500$1.82$463,190.00View SEC Filing  
4/16/2013Mark BagarazziInsiderBuy60,000$0.56$33,600.00View SEC Filing  
4/2/2013Jong Joseph KimCEOBuy90,000$0.50$45,000.00View SEC Filing  
3/22/2013Angel CabreraDirectorBuy40,000$0.54$21,600.00View SEC Filing  
3/20/2013Jong Joseph KimCEOBuy60,000$0.53$31,800.00View SEC Filing  
3/20/2013Niranjan SardesaiCOOBuy25,000$0.53$13,250.00View SEC Filing  
1/15/2013Morton CollinsDirectorBuy100,000$0.67$67,000.00View SEC Filing  
11/14/2012Austin W & Greenhouse Da MarxeMajor ShareholderSell622,550$0.53$329,951.50View SEC Filing  
8/15/2012Angel CabreraDirectorBuy75,000$0.59$44,250.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Inovio Pharmaceuticals (NASDAQ:INO)
DateHeadline
News IconSevere Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2016 - New Market Report (NASDAQ:INO)
reports.pr-inside.com - September 27 at 10:15 AM
News IconBiotech news that matter for investors: Kite Pharma, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:INO)
voiceregistrar.com - September 23 at 5:19 PM
News IconAnalysts Valuations For Two Stocks: Inovio Pharmaceuticals Inc (NASDAQ:INO), Bill Barrett Corporation (NYSE:BBG) - The Voice Registrar (NASDAQ:INO)
voiceregistrar.com - September 23 at 8:35 AM
News IconBiotech Stocks Worth a Closer Look: Inovio Pharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:INO)
voiceregistrar.com - September 22 at 3:41 PM
News IconHot Biotech Stocks Recap: Cerus Corporation (NASDAQ:CERS), Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - The Voice Registrar (NASDAQ:INO)
voiceregistrar.com - September 21 at 9:49 AM
News IconAnalysts Valuations For Two Stocks: Abraxas Petroleum Corp ... - The Voice Registrar (NASDAQ:INO)
voiceregistrar.com - September 14 at 5:45 PM
News IconHC Stocks to Path= Inovio Pharmaceuticals Inc (INO), Palatin Technologies, Inc. (NYSEMKT:PTN) - share market updates (press release) (NASDAQ:INO)
sharemarketupdates.com - September 14 at 5:45 PM
fool.com logoInovio Pharmaceuticals, Inc. in 3 Charts - Motley Fool (NASDAQ:INO)
www.fool.com - September 14 at 5:45 PM
capitalcube.com logoInovio Pharmaceuticals, Inc. – Value Analysis (NASDAQ:INO) : September 14, 2016 (NASDAQ:INO)
www.capitalcube.com - September 14 at 5:45 PM
investopedia.com logoInovio’s Zika Vaccine Bags Tech Award (INO) (NASDAQ:INO)
www.investopedia.com - September 14 at 9:52 AM
fool.com logoInovio Pharmaceuticals, Inc. in 3 Charts (NASDAQ:INO)
www.fool.com - September 13 at 4:51 PM
capitalcube.com logoInovio Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : INO-US : September 13, 2016 (NASDAQ:INO)
www.capitalcube.com - September 13 at 10:28 AM
investopedia.com logoInovio's Race to Kill the Zika Virus (INO) (NASDAQ:INO)
www.investopedia.com - September 12 at 5:31 PM
investopedia.com logoThe Race to Kill the Zika Virus (INO) (NASDAQ:INO)
www.investopedia.com - September 12 at 5:31 PM
publicnow.com logoInovio’s Zika Vaccine Selected As 2016 Technology Breakthrough (NASDAQ:INO)
www.publicnow.com - September 12 at 10:22 AM
News IconInovio Pharmaceuticals, Inc Pipeline Review, Market Share, Size and Clinical trial 2016 - 2020 - Medgadget (blog) (NASDAQ:INO)
www.medgadget.com - September 10 at 10:01 AM
News IconHC Stocks Updates= Teva Pharmaceutical Industries Ltd (TEVA), Inovio Pharmaceuticals Inc (NASDAQ:INO) - share market updates (press release) (NASDAQ:INO)
sharemarketupdates.com - September 9 at 10:22 AM
News IconLooking Ahead for Inovio Pharmaceuticals, Inc. (NASDAQ:INO); Are ... - Frisco Fastball (NASDAQ:INO)
friscofastball.com - September 8 at 5:32 PM
News Icon2 Biotech Stocks News And Price Trends: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Cempra, Inc. (NASDAQ:CEMP) - The Voice Registrar (NASDAQ:INO)
voiceregistrar.com - September 7 at 9:05 AM
News IconStocks Dominating Wall Street: Mylan N.V. (NASDAQ:MYL), Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Street Wise Report (press release) (blog) (NASDAQ:INO)
streetwisereport.com - September 6 at 10:23 AM
fool.com logoWhy Inovio Pharmaceuticals Isn't the Best Zika Stock Right Now (NASDAQ:INO)
www.fool.com - September 5 at 10:00 AM
News IconInovio Pharmaceuticals, Inc. Pipeline Review, Market Share, Strategy, Size and Forecast 2016 - 2020 - Medgadget (blog) (NASDAQ:INO)
www.medgadget.com - September 3 at 10:11 AM
News IconHot Stock Alert - Inovio Pharmaceuticals, Inc.'s (INO) - Hot Stocks Point (NASDAQ:INO)
www.hotstockspoint.com - September 2 at 5:36 PM
benzinga.com logoHow The Zika Virus Spread While Congress Was Out On Recess - Benzinga (NASDAQ:INO)
www.benzinga.com - September 2 at 5:36 PM
finance.yahoo.com logoHow The Zika Virus Spread While Congress Was Out On Recess (NASDAQ:INO)
finance.yahoo.com - September 2 at 5:36 PM
News IconPennsylvania firm launches experimental Zika vaccine clinical trial in Puerto Rico (NASDAQ:INO)
www.sfltimes.com - September 1 at 5:33 PM
bloomberg.com logoTakeda Gets Up to $312 Million in U.S. Funding for Zika Vaccine (NASDAQ:INO)
www.bloomberg.com - September 1 at 5:33 PM
finance.yahoo.com logoInovio Pharmaceuticals to Present at Upcoming Investment Conferences (NASDAQ:INO)
finance.yahoo.com - September 1 at 5:33 PM
prnewswire.com logoTechnical Roundup on Biotech Stocks -- Keryx Biopharma, Inovio Pharma, Seattle Genetics, and Arrowhead Pharma - PR Newswire (press release) (NASDAQ:INO)
www.prnewswire.com - August 31 at 10:27 AM
News IconActive biotech company shares in the news: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Raptor Pharmaceuticals Corp ... - The Voice Registrar (NASDAQ:INO)
voiceregistrar.com - August 31 at 10:27 AM
News IconZika vaccine: Inovio starts clinical study in Puerto Rico (NASDAQ:INO)
outbreaknewstoday.com - August 30 at 8:50 AM
News IconTechnical Roundup on Biotech Stocks -- Keryx Biopharma, Inovio Pharma, Seattle Genetics, and Arrowhead Pharma (NASDAQ:INO)
www.kait8.com - August 30 at 8:50 AM
capitalcube.com logoInovio Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : INO-US : August 30, 2016 (NASDAQ:INO)
www.capitalcube.com - August 30 at 8:50 AM
finance.yahoo.com logoInovio Stock Up as Second Zika Virus Vaccine Study Begins (NASDAQ:INO)
finance.yahoo.com - August 30 at 8:50 AM
schaeffersresearch.com logoBuzz Stocks: Mylan NV, Inovio Pharmaceuticals Inc, and Herbalife Ltd. - Schaeffers Research (blog) (NASDAQ:INO)
www.schaeffersresearch.com - August 29 at 5:30 PM
streetinsider.com logoInovio Pharma (INO) Commences Zika Vaccine Study in Puerto Rico - StreetInsider.com (NASDAQ:INO)
www.streetinsider.com - August 29 at 5:30 PM
finance.yahoo.com logoPennsylvania firm launches Zika vaccine trial in Puerto Rico (NASDAQ:INO)
finance.yahoo.com - August 29 at 5:30 PM
thestreet.com logoInovio (INO) Stock Climbs, Launches Zika Vaccine Trial (NASDAQ:INO)
www.thestreet.com - August 29 at 5:30 PM
blogs.barrons.com logoInovio: Let's Hear It For Zika! (NASDAQ:INO)
blogs.barrons.com - August 29 at 5:30 PM
bizjournals.com logoInovio launches second human study of potential Zika vaccine in Puerto Rico (NASDAQ:INO)
www.bizjournals.com - August 29 at 5:30 PM
reuters.com logoBRIEF-Inovio launches Zika vaccine trial (NASDAQ:INO)
www.reuters.com - August 29 at 10:10 AM
rttnews.com logoInovio Unveils Zika Vaccine Trial In Midst Of Puerto Rico Epidemic (NASDAQ:INO)
www.rttnews.com - August 29 at 10:10 AM
streetinsider.com logoInovio Pharma (INO) Commences Zika Vaccine Study in Puerto Rico (NASDAQ:INO)
www.streetinsider.com - August 29 at 10:10 AM
marketwatch.com logoInovio launches Zika vaccine trial in Puerto Rico (NASDAQ:INO)
www.marketwatch.com - August 29 at 10:10 AM
nasdaq.com logoInovio Launches Zika Vaccine Trial in Midst of Puerto Rico Epidemic to Explore Early Signals of Vaccine Efficacy (NASDAQ:INO)
www.nasdaq.com - August 29 at 10:10 AM
investorplace.com logo3 Stocks to Watch on Monday: Ford Motor Company (F), General Motors Company (GM), Inovio Pharmaceuticals Inc (INO) (NASDAQ:INO)
investorplace.com - August 29 at 8:28 AM
News IconInovio Expands Ebola Vaccine Trial (NASDAQ:INO)
jutiagroup.com - August 25 at 10:39 AM
News IconInovio Expands Ebola Vaccine Trial INO (NASDAQ:INO)
www.investorideas.com - August 25 at 10:39 AM
News IconInovio Pharmaceuticals, Inc. (INO) - Strategic and Financial SWOT Analysis Review (NASDAQ:INO)
emailwire.com - August 24 at 5:31 PM
News IconInteresting INO Put And Call Options For October 21st (NASDAQ:INO)
www.stockoptionschannel.com - August 23 at 10:01 AM

Social

Inovio Pharmaceuticals (NASDAQ:INO) Chart for Tuesday, September, 27, 2016


Last Updated on 9/27/2016 by MarketBeat.com Staff